Classify Rx for pharmacology
53
Quality Score
Solid
Classify Rx for pharmacology
Medium confidence
✍️ bumetric analysis
“
Classify Rx for pharmacology is an Android app from Nishith Sekhar Revappala in the Medical category, currently rated 3.9★ across 724 ratings. Initial signal reads as mixed reviews: supporters praise core features while critics cite stability and value gaps.
Quality Score is 53: Solid (established niche player). For a Medical app, that means established niche player. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
💰 Monthly revenue · now vs forecast
● Right now
$200
per month
→
12-mo forecast
$100 – $931
per month
→
24-mo forecast
$100 – $2790
per month
MICRO tier
💡 Grow this revenue
Free AI audit of this app’s store listing
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
Typical impact: +2-5× organic installs
📊 Performance Tracking LIVE
Loading…
Rating
—
Reviews
—
Forecast Revenue / mo
—
Snapshots tracked
0
since first record
🍎Also on iOS
$975/mo · 11 ratings · 5.0★
View →
ONE-TIME · BUILD
💰 Estimated build cost
$145K
↳ What it cost to build · not monthly revenue
Likely range $110K – $195K
$25K · MVP floor
$100K · indie scale
$500K+ · studio build
📈
Slow ROI — current MRR is well below build cost
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
Where the money goes
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| 💎 In-app purchase plumbing | +$9K |
| ⚙ Medical complexity ×1.55 | +$32K |
| 🌐 Cross-platform reach (iOS + Android) | +$50K |
Total estimate
$145K
👥 Estimated audience size
39K
Lifetime downloads (US-equivalent)
Monthly active
9.8K
Daily active
1.9K
Synthetic estimate from ratings × category benchmarks. Calibrated against 2024-2026 mobile-attribution retention + DAU/MAU reports. Numbers are US-storefront-equivalent — true global audience can be 5-10× larger for international apps. Full math + source list on /methodology.
How we sized it
| 📲 Medical engagement | ~55 installs / rating |
| 🔁 Medical D30 retention | 25% |
| 📍 DAU / MAU stickiness | 0.20 |
DAU / MAU
19% sticky
🔬
How we forecast this revenue
LOW CONFIDENCEBaseline
$200/mo · ML-estimated from 234 triggers
Growth rate
+8.0% MoM · MICRO tier baseline (compound monthly)
6 months
$127 – $508
12 months
$100 – $931
24 months
$100 – $2.8K
Compound growth at +8.0% MoM (tier baseline for MICRO). Range widens with horizon — typical noise band ±60% at 6mo.. Ranges widen with horizon — distant futures carry more uncertainty.
📊
BU Investment Matrix
Insufficient data · 35/100MICRO TIERtoo early to scoreGrowth Velocity
5.0
Founder Strength
3.8
Product Quality
4.2
Revenue Strength
2.3
Monetization Maturity
1.0
Defensibility
3.5
Market Position
0.0
Operational Safety
8.0
- 💰 Revenue: Marginal — $0 - $500/mo · MICRO tier · indicative confidence, trajectory unclear.
- ⭐ Quality: 3.0★ across 536 reviews — weak — significant quality concerns.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: Insufficient signal to assess trajectory.
- ⚠️ Risk: Moderate — no material risk signals detected.
🎯 For competitors: Mixed picture. Worth competing if you have a clear UX or pricing edge — otherwise crowded segment.
💵 For acquirers: Estimated asking range 18-32× monthly = $3K-$6K. Portfolio play ($568/mo combined) commands premium.
Composite of 8 dimensions computed deterministically from public signals — no LLM, every score traces back to a measurable input. Default weights shown; "compete" / "acquire" / "invest" lenses re-weight without re-fetching.
Range:
💰 Forecast Revenue / mo
MODELRevenue forecast computed from BU's 234 trigger model on each snapshot. Calibrated against ground-truth from 58 verified-revenue apps.
🔬Forecast Breakdown — Why This Estimate?Top 3 of 3 triggers
Our ML model uses 200+ signals from public data. These are the most influential for this app:
| Mature app (9y old)METRIC | +$1,500 | |
| Ad-supported / freemiumMETRIC | +$600 | |
| Early-stage install base (724 ratings)METRIC | +$400 |
METRIC = structural app data · REVIEW = mined from user reviews · ✓ VERIFIED = Stripe-verified anchor (TrustMRR)
📈 Reviews Growth
LIVECumulative review count from first BU snapshot. Each point = a tracked update.
⭐ Rating Trend
LIVEAverage rating evolution. Updates with each new review batch.
Profile & Insights
Everything we know — and don't — about this app and its company.
Identification
- App name
- Classify Rx for pharmacology
- Developer
- Nishith Sekhar Revappala
- Bundle ID
- com.first.medical.medical
- App Store URL
- Open in App Store
- Category
- Medical
- Content rating
- Not found
- Languages
- Not found
Company
- Website
- simplifydrugs.blogspot.com
- Tagline
- Not found
- Description
- Not found
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Not found
Revenue
- Verified revenue / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- ML model estimate / mo
- $376/mo
- Top-grossing rank
- Not found
- All-time revenue
- Not found
- Pricing
- $19.99 per item
Founder
Founder data not yet collected for this app.
Funding
Funding data not yet collected for this app.
Press & Links
Press & Links data not yet collected for this app.
Contacts & Socials
Contacts & Socials data not yet collected for this app.
📈Ratings growth724 ratings+25% lifetimeShow 3-year history estimate ▾
Tracked (1 weeks) Pre-tracking estimate (37 weeks) · model-based, ±5% noise · anchored to release date and current value
Profile is built from iTunes Lookup + developer site scrape + ML revenue model. Empty fields show "Not found" — additional sources (Crunchbase, X, IndieHackers, Acquire.com) coming.
📝 About this app
"ILLUSTRATIONS ARE HERE"
Classify gives the classification of all the drugs in a simple format. Along with that we now have complete description of all drugs, topics and chapters (pro feature). But yeah, Central Nervous System (CNS) is completely free
The best pharmacology review app on your smartphone. Content is handcrafted for smartphone experience.
The app is suitable for all medical students and other healthcare professionals who are preparing for pharmacology examinations.… View full description on the official store →
Classify gives the classification of all the drugs in a simple format. Along with that we now have complete description of all drugs, topics and chapters (pro feature). But yeah, Central Nervous System (CNS) is completely free
The best pharmacology review app on your smartphone. Content is handcrafted for smartphone experience.
The app is suitable for all medical students and other healthcare professionals who are preparing for pharmacology examinations.… View full description on the official store →
App Specs
🔐 Own this app? Claim & verify MRR →🔖 v5.0.0🔄 updated 0d ago📂 Medical💰 Free📺 Ad-supported💎 IAP $19.99 per item
🔔
Track this app’s revenue
FREEGet an email when revenue moves by your threshold. No spam, unsubscribe in one click.
📝 Description
95
BU Score · Transcendent
Full revenue analysis
Read the article-style breakdown for Classify Rx for pharmacology: category rank, percentile, growth signal, comparable apps, and how the forecast is calibrated against verified-MRR anchors in this niche.
More by Nishith Sekhar Revappala
View all →📦 Portfolio summaryINDIE studio
3apps·$1K/mocombined
Lead-app heavy — top app contributes 68%
About this analysis
Why medium confidence: 724 ratings · no founder-verified revenue (model estimate only).
❓ Frequently Asked Questions
4 answers · auto-generated from this app's public dataHow much does Classify Rx for pharmacology make per month?▴
Based on our ML-calibrated revenue forecast, Classify Rx for pharmacology earns approximately $376/mo. This is a US-storefront-equivalent estimate; global revenue can be several times larger for internationally-distributed apps. See the methodology page for the full formula and confidence bands.
What apps are like Classify Rx for pharmacology?▴
Browse the full Medical category catalog to find similar apps with revenue, build cost, audience and tech stack data. Each /p/{slug} page also shows a Compare side-by-side widget with three peer apps from the same niche.
Who makes Classify Rx for pharmacology?▴
Classify Rx for pharmacology is published by Nishith Sekhar Revappala on the Google Play Store. See the full publisher portfolio (other apps by the same developer) via the More by developer block on the product page above.
What is Classify Rx for pharmacology's BU Score?▴
Classify Rx for pharmacology has a BU Score of 53/100 (Solid). The score combines App Store rating, ratings count, monetization model and revenue signals calibrated against founder-verified MRR anchors. See the BU Score formula.